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Abstract
Background Cancer cachexia is a complex syndrome characterized by an ongoing loss of skeletal muscle mass and progres-
sive functional impairment. A proactive management approach is recommended, including physical exercise to maintain
function via modulation of muscle metabolism, insulin sensitivity and levels of inﬂammation. The review aimed to determine
the safety, acceptability and effectiveness of exercise in adults with cancer cachexia. Secondary aims, subject to the data
availability, were to compare effectiveness according to the characteristics of the study intervention or population.
Methods We sought randomised controlled trials (RCTs) in adults meeting international criteria for cancer cachexia, comparing
a programme of exercise as a sole or adjunct intervention to usual care or an active control. CENTRAL, MEDLINE, EMBASE, DARE
and HTA, ISI Web of Science, LILACS, PEDro, SciVerse SCOPUS, Biosis Previews PreMEDLINE and Open Grey databases were
searched up to June 2014. Two authors independently assessed studies for eligibility.
Results We screened 3154 separate titles and abstracts, and reviewed 16 full-texts. Corresponding authors were contacted
to determine if samples met cachexia staging criteria. Most authors did not explore this concept. No trial met review eligibility
criteria. We were unable to perform a meta-analysis to determine any effects from exercise intervention.
Conclusion Despite a strong rationale for the use of exercise, there is insufﬁcient evidence to determine safety and effective-
ness in patients with cancer cachexia. Findings from ongoing studies are awaited. Assessment of cachexia domains, ideally
against international criteria, is required for future trials of exercise and supportive care interventions.
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Introduction
Cancer cachexia is characterized by an ongoing loss of skele-
tal muscle mass, with or without a loss of fat mass, leading to
progressive functional impairment.1 Prevalence varies ac-
cording to cancer type, with the highest rates found for can-
cers of the lung and upper gastrointestinal tract, where over
half of all patients are affected at diagnosis.1,2 Variation in
the development of cancer cachexia also occurs on an indi-
vidual level, with genetic polymorphisms inﬂuencing hall-
marks of the syndrome, for example inﬂammation, loss of
lean or fat mass..3 The pathophysiology of cancer cachexia
is complex but involves a combination of abnormal metabo-
lism and a negative energy balance.4 Functional conse-
quences of cachexia include limiting symptoms,5 reduced
muscle function,6,7 reduced exercise capacity,8 and physical
inactivity,9 all of which impact adversely on a patient’s level
of independence (Figure 1).
A proactive management approach is recommended, insti-
gated before cachexia becomes refractory, with the aim to
maintain or slow down the decline in physical function.1,4
Multimodal intervention is also considered necessary, as it
is unlikely any single intervention will address the metabolic,
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nutritional, and functional deﬁcits caused by cachexia
concurrently.4 Three main component interventions are be-
ing developed: nutritional therapies, pharmacological agents,
and exercise therapies.10
Exercise is deﬁned as ‘a planned, structured and repetitive
bodily movement done to maintain or improve one or more
components of physical ﬁtness’.11 Exercise programmes vary
according to the frequency, intensity, volume, and type of
training used, as well as contextual factors such as the setting
and level of supervision. For example, both a 6 week hospital-
based programme of twice weekly, high-intensity, treadmill
walking, and a home-based programme of low-intensity,
balance training throughout chemotherapy would be deﬁned
as exercise.11 Exercise may attenuate the effects of cancer
cachexia via modulation of muscle metabolism, insulin sensi-
tivity, and levels of inﬂammation.12,13 Exercise may help
patients with or at risk of cancer cachexia tomaintain their inde-
pendence for longer, but empirical evidence is lacking. Despite a
growing evidence base for nutritional and drug interventions for
cancer cachexia,10 studies of exercise in advanced cancer are
few. This paper provides an executive summary of a recent
Cochrane Collaboration systematic review,14 which synthesizes
evidence for the use of exercise for cancer cachexia.
The primary aim was to determine the effectiveness of
exercise, compared with usual care or no treatment on lean
muscle mass in adults with cancer. Secondary aim were to
examine the acceptability and safety of exercise in this setting,
and if possible, to compare effectiveness according to the charac-
teristics of the exercise intervention or patient population.
Methods
Eligibility criteria
Criteria for review entry were randomized controlled trials or
quasi-randomized studies in any setting involving adults (≥18
years of age) with a histological or clinical diagnosis of cancer,
offered any type of exercising programme as a sole inter-
vention or in combination with another intervention. We
adopted an international criteria for cancer cachexia,1 and
patients could be at any stage in the proposed classiﬁcation:
• Pre-cachexia; weight loss ≤5% with anorexia and metabolic
changes
• Cachexia; weight loss >5% in the past six months or body
mass index (BMI) <20 kg/m2 and ongoing weight loss
>2% or sarcopenia, anorexia or systemic inﬂammation
• Refractory cachexia; active catabolism, ongoing weight
loss, not responsive to treatment, and life expectancy of
<3 months.
To include studies in populations relevant to the review,
for example advanced cancer, but not explicitly performed
to address cancer cachexia, we permitted studies where
≥50% of participants fell within the cachexia deﬁnitions.
Where baseline demographic data were insufﬁcient to assess
participants against these criteria, we contacted study authors
to seek additional data for this purpose.
Outcome measures
The primary endpoint was lean body mass assessed at the
ﬁrst study timepoint following a programme of exercise.
Secondary outcomes included adherence to prescribed
programmes, occurrence of adverse events and, subject to
availability of data, muscle strength and endurance, maximal
and submaximal exercise capacity, fatigue, and health-related
quality of life.
Search strategy
We developed a comprehensive search strategy using a com-
bination of terms based on the target population and inter-
vention. The following electronic databases were searched
from their inception until June 2014, CENTRAL, MEDLINE
(Ovid), EMBASE (Ovid), DARE and HTA - Health Technology
Assessments (on The Cochrane Library), ISI Web of Science
(SCI-Expanded and CPCI), LILACS (Latin American and
Caribbean Health Sciences), PEDro (the Physiotherapy
Evidence Database), SciVerse SCOPUS; Biosis Previews
PreMEDLINE, Open Grey (System for Information on Grey
Literature).We identiﬁed ongoing studies using: Clinical
Trials.gov; metaRegister of Controlled Trials (mRCT); Interna-
tional Clinical Trials Registry Platform (ICTRP); Pan African
Clinical Trials; and the EU Clinical Trials Register. In addition,
we hand-searched the following sources: proceedings from
the Society on Sarcopenia, Cachexia and Wasting Disorders
(SCWD); the American Cancer Society; the British Association
for Cancer Research; and the European Clinical Guidelines.
We checked reference lists and citation reports of studies review
in full text. In addition, we contacted corresponding authors,
Figure 1 Functional impairments and consequences of cancer cachexia.
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experts, and organizations in the ﬁeld to seek potentially
relevant research, including unpublished and ongoing studies.
Data collection and analysis
Two review authors (A.J.G., V.S.) independently assess titles
and abstracts of articles for relevance.14 We extracted
relevant data relating to the study source, methods, partici-
pants, and intervention, Disagreements were discussed and
resolved by consensus. We planned for two authors to inde-
pendently assess each eligible study for risk of bias using the
Cochrane Collaboration tool.15
Results
We identiﬁed 4786 references from the search. From a total of
3154 references after duplicates were removed, 3138 were
deemed ineligible after title and abstract screening (Figure 2).
Full texts of the remaining 16 potentially relevant titles were re-
trieved.14 We attempted to contact corresponding authors via
electronic mail to determine the proportion of the sample
meeting pre-cachexia or cachexia criteria. Most authors did not
explore this concept, and others did not respond.14 We did not
identify any suitable studies for inclusion. In the absence of
any suitable trials, we were unable to perform a meta-analysis
to determine any effects from exercise intervention.
Discussion
Using a comprehensive and systematic search strategy, we
identiﬁed no randomized controlled trials of exercise for pa-
tients with cancer cachexia. In studies where exercise inter-
ventions were delivered to patients with cancer and at risk
of cachexia, domains for the syndrome including weight loss,
nutritional stores and intake, and muscle mass or function
were seldom reported. To this end, it was not possible to
determine the proportion of patients meeting pre-cachexia
or cachexia criteria.
The lack of studies in this ﬁeld is at odds with the strong
rationale for examining exercise as a therapeutic interven-
tion. Reviews have outlined the potential for exercise to
impact positively on muscle mass and strength,16 inﬂamma-
tory markers,13 and physical function,12 all of which are fea-
tures of cancer cachexia which impairment the patient. It is
plausible that the previous lack of a consensus deﬁnition
has hindered study in the ﬁeld. Without agreed diagnostic
or staging criteria, the prevalence and impact of cancer ca-
chexia have been difﬁcult to assess. Moreover, interventions
may have been inadvertently trialled in cachectic groups
without formal recognition, as may be the case for exercise
studies in advanced cancer. In this regard, the classiﬁcation
system proposed by Fearon et al.1 is an important step
forward, and recent international validation studies will add
further momentum.17–20
Two candidate studies may have included patients with
cancer cachexia, although this cannot be conﬁrmed. The
ﬁrst21 tested a multidisciplinary intervention with cognitive,
emotional, social, and spiritual supportive care delivered over
eight 90min sessions. In 115 patients with advanced cancer
undergoing radiation therapy, self-assessed physical well-
being was improved in the intervention group, although no
beneﬁt in objectively measured physical function was ob-
served. The second22 randomized 231 patients with incur-
able, metastatic cancer to physical exercise or usual care
over 8weeks. The exercise was delivered in two 60min ses-
sion each week, and led to improvements in handgrip
strength and sit-to-stand performance. No adverse effects
related to exercise were found in either study.
We also identiﬁed ongoing studies targeting cancer ca-
chexia, most notably a randomized feasibility trial of a 6 week
multimodal intervention comprising nutritional supplementa-
tion, home-based exercise, and anti-inﬂammatory treatment
for patients with advanced non-small cell lung or pancreatic
cancer (NCT01419145). Further ongoing studies are examining
combined physical activity/exercise and nutrition inter-
ventions, over 12weeks for patients with head and neck
cancer during or following treatment (NCT01681654) and
over 20weeks for cachectic patients with lung cancer
(ACTRN12611000870954). Findings from these trials are
eagerly awaited and will pave the way for future exercise
interventions for cachexia.
Figure 2 Review ﬂow diagram.
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Conclusions
There is insufﬁcient evidence to determine the safety and
effectiveness of exercise for patients with cancer cachexia.
Despite a strong rationale for the use of exercise, there are
no present data from RCTs to elucidate the speciﬁc effects
in this population. International criteria to diagnose and
classify cancer cachexia provide a strong basis to deﬁne study
populations within trials of interventions for this condition.
An assessment of these domains must be included in cachexia
trials and is strongly encouraged in populations where
cachexia may be present. This would enhance the interpreta-
tion and generalization of ﬁndings from relevant study popu-
lations to the cachexia setting.
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